| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | LXS-196 |
|---|
| Description | LXS-196 is an orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration, LXS-196 binds to and inhibits PKC, which prevents the activation of PKC-mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. MW: 472.5. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide; NVP-LXS196 |
|---|
| Gene, Accession, CAS # | CAS: 1874276-76-2 |
|---|
| Catalog # | B2092-5 |
|---|
| Price | |
|---|
| Order / More Info | LXS-196 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|